Search Results - "Powderly, WG"

Refine Results
  1. 1
  2. 2
  3. 3

    Nontuberculous pyogenic spinal infection in adults : A 12-year experience from a tertiary referral center by BUTLER, Joseph S, SHELLY, Martin J, TIMLIN, Marcus, POWDERLY, William G, O'BYRNE, John M

    Published in Spine (Philadelphia, Pa. 1976) (01-11-2006)
    “…We performed a retrospective review of 48 cases of pyogenic spinal infection presenting over a 12-year period to the National Spinal Injuries Unit (NSIU) of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV by Lundgren, JD, Battegay, M, Behrens, G, De Wit, S, Guaraldi, G, Katlama, C, Martinez, E, Nair, D, Powderly, WG, Reiss, P, Sutinen, J, Vigano, A

    Published in HIV medicine (01-02-2008)
    “…Background Metabolic diseases are frequently observed in HIV‐infected persons and, as the risk of contracting these diseases is age‐related, their prevalence…”
    Get full text
    Journal Article
  6. 6

    Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States by OSTROSKY-ZEICHNER, Luis, REX, John H, MANGINO, Julie E, LEE, Jeannette, PAPPAS, Peter G, HAMILL, Richard J, LARSEN, Robert A, HOROWITZ, Harold W, POWDERLY, William G, HYSLOP, Newton, KAUFFMAN, Carol A, CLEARY, John

    Published in Antimicrobial Agents and Chemotherapy (01-10-2003)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  7. 7

    An objective case definition of lipodystrophy in HIV-infected adults: a case-control study by Carr, Andrew

    Published in The Lancet (British edition) (01-03-2003)
    “…Lipodystrophy (peripheral lipoatrophy, central fat accumulation, and lipomatosis) is a common and disfiguring problem in adult patients with HIV-1 infection on…”
    Get full text
    Journal Article
  8. 8

    Longitudinal Evolution of Bone Mineral Density and Bone Markers in Human Immunodeficiency Virus—Infected Individuals by Mondy, Kristin, Yarasheski, Kevin, Powderly, William G, Whyte, Michael, Claxton, Sherry, DeMarco, Debra, Hoffmann, Mary, Tebas, Pablo

    Published in Clinical infectious diseases (15-02-2003)
    “…The underlying mechanisms of several bone disorders in human immunodeficiency virus (HIV)–infected persons and any relation to antiretroviral therapy have yet…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy by TEBAS, P, POWDERLY, W. G, CLAXTON, S, MARIN, D, TANTISIRIWAT, W, TEITELBAUM, S. L, YARASHESKI, K. E

    Published in AIDS (London) (10-03-2000)
    “…The use of highly active antiretroviral therapy (HAART) has been associated with multiple metabolic complications whose pathogenesis is poorly understood at…”
    Get full text
    Journal Article
  14. 14

    Undetectable Plasma HIV RNA Load Predicts Success after Hepatitis B Vaccination in HIV-Infected Persons by Overton, Edgar Turner, Sungkanuparph, Somnuek, Powderly, William G., Seyfrieds, Warren, Groger, Richard K., Aberg, Judith A.

    Published in Clinical infectious diseases (01-10-2005)
    “…Human immunodeficiency virus (HIV)—infected patients respond poorly to hepatitis B vaccination. Records of 194 HIVinfected patients were reviewed for factors…”
    Get full text
    Journal Article
  15. 15

    Long-term Exposure to Lifelong Therapies by Powderly, William G

    “…Three categories of highly active antiretroviral therapy (HAART)associated major toxic effects have been identifiednucleoside-related toxic effects (e.g.,…”
    Get full text
    Journal Article
  16. 16

    Alendronate, Vitamin D, and Calcium for the Treatment of Osteopenia/Osteoporosis Associated With HIV Infection by Mondy, Kristin, Powderly, William G, Claxton, Sherry A, Yarasheski, Kevin H, Royal, Michael, Stoneman, John S, Hoffmann, Mary E, Tebas, Pablo

    “…BACKGROUND:Osteopenia and osteoporosis are frequent complications of HIV infection and/or its treatment. Alendronate is the only bisphosphonate approved for…”
    Get full text
    Journal Article
  17. 17

    Antiretroviral Activity of the Anti-CD4 Monoclonal Antibody TNX-355 in Patients Infected with HIV Type 1 by Kuritzkes, Daniel R., Jacobson, Jeffrey, Powderly, William G., Godofsky, Eliot, DeJesus, Edwin, Haas, Frances, Reimann, Keith A., Larson, Jeffrey L., Yarbough, Patrice O., Curt, Valentin, Shanahan, William R.

    Published in The Journal of infectious diseases (15-01-2004)
    “…BackgroundWe wished to determine the safety and anti–human immunodeficiency virus (HIV) type 1 activity of single doses of TNX-355, a humanized IgG4 anti-CD4…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Switching Effective Antiretroviral Therapy: A Review by Mayer, Kenneth H., Drechsler, Henning, Powderly, William G.

    Published in Clinical infectious diseases (15-11-2002)
    “…One approach to target the long-term metabolic toxicity and disfiguring body-shape changes associated with antiretroviral therapy is to switch one component of…”
    Get full text
    Journal Article
  20. 20

    The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling by Wang, Michael W.-H., Wei, Shi, Faccio, Roberta, Takeshita, Sunao, Tebas, Pablo, Powderly, William G., Teitelbaum, Steven L., Ross, F. Patrick

    Published in The Journal of clinical investigation (15-07-2004)
    “…Highly active antiretroviral therapy (HAART), which includes HIV protease inhibitors (PIs), has been associated with bone demineralization. To determine if…”
    Get full text
    Journal Article